Ancora Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Ancora Advisors's ELV Position: Q2 2026 in Review
Ancora Advisors reduced its Elevance Health (ELV) stake by 57% in Q2 2026, selling an estimated $87.5K and leaving 178 shares worth $68.8K. The position accounts for ﹤0.01% of the portfolio, ranked #986.
Ancora Advisors first reported a position in ELV in Q3 2018 and has held it in 28 quarters since. The position peaked at $121K in Q1 2026. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Ancora Advisors held 178 shares of Elevance Health worth $68.8K as of Q2 2026.
- Ancora Advisors sold 236 Elevance Health shares in Q2 2026, an estimated $87.5K.
- Elevance Health made up ﹤0.01% of Ancora Advisors's portfolio in Q2 2026, its #986 holding.
- Ancora Advisors first reported a position in Elevance Health in Q3 2018 and has held it in 28 quarters since.
- Ancora Advisors's Elevance Health position peaked at $121K in Q1 2026.
- 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Ancora Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.